Since its establishment in 2014, the Asian Society of Cryosurgery （ASC） has experienced five sessions of general elections, and the Society has always adhered to the original targets, operating strictly in accordance with the work constitution of the ASC, conducted more than one hundred academic exchanges of various scales, orgnizing the writing of expert consensus on cryoablation of lung cancer, liver cancer, bone and soft tissue tumors and pancreatic cancer published in domestic and international journals and were widely cited, which has made great contributions to the promotion of cryotherapy.

The end of the year 2022 is the time for the general election of the 6th ASC, and the preparatory committee was established at the end of October, and there were many consultations and discussions on the specific matters of the establishment of the new academic society. The new ASC academic group is open to all of the Asia in accordance with the ASC constitution, and the qualifications for applicants are defined for all types of scholars engaged in various clinical cryotherapy and basic cryonics research, as well as detailed regulations for the different positions in the ASC, including years of practice, published papers and achievements, work experience, etc. Up to November 25, 2022, over 800 scholars have submitted their applications, and over 500 have met the requirements for membership after careful screening. Such a booming application trend is the first time in the history of the ASC, showing a large group of cryomedcine practitioners and high motivation for academic participation.

Prof. Xiao Yueyong, Chairman of the Preparatory Committee, said, " Based on the current applications, cryomedicine is a multidisciplinary technology that involves basic research on cryomedcine, cryo-preservation, cryo-ablation and cryo-immunization. In the future, the Society will become an open, multi-element academic group with members in the field of cryosurgery, dermatology, gynecology, plastic surgery and basic cryonics research. The proportion of interventionalists in the membership of the Society will be reduced, but cryoablation of tumor is still an important tool for oncology treatment that the Society needs to develop and promote. He personally gave high expectations for the future development of the ASC and expressed his vigorous support for the new ASC academic group that will be re-elected soon.

亚洲冷冻治疗学会换届申请呈现火爆现象

亚洲冷冻治疗学会自2014年成立以来经过了5届的换届选举，学会始终秉承学会成立之初的目标，严格按照亚冷会的工作章程运行，进行了百余场各种规模的学术交流，牵头撰写的有关肺癌、肝癌、骨与软组织肿瘤和胰腺癌冷冻消融的专家共识在国内外刊物发表并被广泛引用，对冷冻治疗的技术推广做出了巨大贡献。

2022年底是亚洲冷冻治疗学会的换届选举时间，筹备委员会在10月底成立，对新一届学术团体成立的具体事宜多次进行了磋商和讨论。新一届亚冷会学术团体在遵循亚冷会章程的情况下面向全亚洲开放，对申请人员的资格做了规定，申请者为从事各种临床冷冻治疗、冷冻基础研究的各类学者，对亚冷会不同的任职层次也做了细致的规定，包括从业时间、发表论文和成果，工作经验等等。截止2022年11月25日已经有近700名申请者投递了申请，经过对申请表和申请者本人资料的细致筛查有近500名申请者符合入会条件。这样火爆的申请趋势是亚冷会历史上首次出现的，展现了冷冻从业人群广，学术参与积极性高的景象。

筹备委员会主席肖越勇教授说：从目前的申请情况来看，冷冻医疗是一个多学科的技术手段，涉及到冷冻的基础研究、低温保存、冷冻消融和冷冻免疫等。亚冷会未来也必定成为一个开放的、多元素的学术团体，其成员包含从事冷冻治疗的大内外科、皮肤科、妇科、整形外科以及冷冻基础研究的学者。亚冷会成员中介入医生的比例将大大缩小，但是冷冻消融技术仍是目前亚冷会需要开发推广的肿瘤治疗的重要手段。他本人对亚冷会未来的发展给予了很高的希望，并表示将对即将改选出的新的亚冷会学术团体给予大力支持。